Coiled Therapeutics Plc
Total Valuation
USDAs of December 31, 2025, COILED THERAPEUTICS PLC carries a market capitalization of 3.51M, placing it among publicly traded companies globally. Its enterprise value stands at 3.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.51M |
| Enterprise Value | 3.40M |
Share Statistics
As of December 31, 2025, COILED THERAPEUTICS PLC has 16.37M shares outstanding.
| Shares Outstanding | 16.37M |
Valuation Ratios
These figures are as of December 31, 2025.
| PB Ratio | 1.08 |
| P/TBV Ratio | -16.79 |
Financial Position
As of December 31, 2025, COILED THERAPEUTICS PLC maintains a current ratio of 0.43, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.43 |
| Quick Ratio | 0.29 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 5.50 |
Stock Price Statistics
As of the close on October 20, 2026, COILED THERAPEUTICS PLC's stock has declined approximately 49.88% over the past 52 weeks.
| 52-Week Price Change | -49.88% |
Balance Sheet
USDAs of December 31, 2025, COILED THERAPEUTICS PLC holds 105,171.39 in cash and equivalents against - - in total debt, resulting in a net debt position of -105,171.39. Total book value stands at 3.26M, with working capital of -208,856.58 providing operational flexibility.
| Cash & Cash Equivalents | 105,171.39 |
| Net Debt | -105,171.39 |
| Equity (Book Value) | 3.26M |
| Book Value Per Share | 0.20 |
| Working Capital | -208,856.58 |
Stock Splits
COILED THERAPEUTICS PLC's most recent stock split took place on March 27, 2026 with a 10:1 split ratio.
| Last Split Date | 3/27/2026 |
| Split Ratio | 10:1 |